Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata).
Original language | English |
---|---|
Journal | BMJ - British Medical Journal - Clinical Research Edition |
Volume | 341 |
Pages (from-to) | c3493 |
ISSN | 0959-8138 |
Publication status | Published - 1 Jan 2010 |
ID: 34127934